Icon
+91 94997 68112
Login Register

ZYPREXA RELPREVV (nda022173)- (EQ 210MG BASE/VIAL,EQ 300MG BASE/VIAL,EQ 405MG BASE/VIAL)

OLANZAPINE PAMOATE CHEPLAPHARM
EQ 210MG BASE/VIAL,EQ 300MG BASE/VIAL,EQ 405MG BASE/VIAL
No No
2018-Sep-30 Expired
None 2012-Dec-11
None No
ZYPREXA® RELPREVV™ is a long-acting atypical antipsychotic for intramuscular injection indicated for the treatment of schizophrenia.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 210MG BASE/VIAL ** ** - - -
EQ 300MG BASE/VIAL ** ** - - -
EQ 405MG BASE/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report

Download GenUS Detailed Report

To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.